1. LAK activity or TAL and PBL isolated from patients with ascites ovarian tumours;Allavena;J Natl Cancer Inst,1986
2. Lymphocyte cytotoxicity in the peritoneal cavity and blood of patients with ovarian cancer;Berek;Obstet Gynecol,1984
3. Lymphocyte activation by recombinant interleukin-2 in ovarian cancer patients;Boyer;Obstet Gynecol,1989
4. Clonal analysis of T lymphocytes isolated from ovarian carcinoma ascites fluid: phenotypic and functional characterisation of T cell clones capable of lysing autologous carcinoma cells;Ferrini;Int J Cancer,1985
5. Tumour cytolysis by lymphocytes infiltrating ovarian malignant ascites;Ionnides;Cancer Res,1991